BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Eradication rate
1
Precision therapy guided by genotypic antibiotic resistance for Helicobacter pylori eradication: A prospective, randomized controlled trial
11/13/2025 6:51:09 AM | Browse: 159 | Download: 334
2
Efficacy and safety of triple therapy with vonoprazan for Helicobacter pylori eradication: A multicenter, prospective, randomized controlled trial
7/24/2025 7:47:22 AM | Browse: 132 | Download: 474
3
Amoxicillin high-dose dual therapy for Helicobacter pylori primary eradication: Proton pump inhibitor and potassium-competitive acid blocker, which’s better?
4/2/2025 10:54:13 AM | Browse: 276 | Download: 1132
4
Vonoprazan-amoxicillin dual regimen with Saccharomyces boulardii as a rescue therapy for Helicobacter pylori: Current perspectives and implications
3/14/2024 5:31:16 PM | Browse: 240 | Download: 782
5
Success of susceptibility-guided eradication of Helicobacter pylori in a region with high secondary clarithromycin and levofloxacin resistance rates
1/12/2024 8:02:47 AM | Browse: 464 | Download: 1696
6
Statistical proof of Helicobacter pylori eradication in preventing metachronous gastric cancer after endoscopic resection in an East Asian population
8/24/2022 11:31:49 AM | Browse: 501 | Download: 1718
7
Antimicrobial susceptibility testing before first-line treatment for Helicobacter pylori infection in patients with dual or triple antibiotic resistance
5/15/2017 6:16:31 AM | Browse: 1541 | Download: 2266
8
Seven-day triple therapy is a better choice for Helicobacter pylori eradication in regions with low antibiotic resistance
12/9/2015 5:57:00 PM | Browse: 1115 | Download: 2259
9
Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication
7/14/2015 12:17:00 PM | Browse: 1322 | Download: 2931
10
Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication
5/18/2015 5:02:00 PM | Browse: 1208 | Download: 2234
11
Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease
4/27/2015 4:29:00 PM | Browse: 1407 | Download: 2586
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.